*Optimal dilutions/concentrations should be determined by the researcher.
Not tested in other applications.
Influenza virus- infected H1299 lysates , Influenza virus (A/WSN/1933(H1N1))-infected DF-1 cell lysates , *influenza virus (A/WSN/33) infected MDCK cells
1XPBS, 1% BSA, 20% Glycerol (pH7). 0.01% Thimerosal was added as a preservative.
Store as concentrated solution. Centrifuge briefly prior to opening vial. For short-term storage (1-2 weeks), store at 4ºC. For long-term storage, aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles.
1mg/ml(Please refer to the vial label for the specific concentration.)
Influenza A virus ( H1N1)
Recombinant fragment corresponding to C-terminal region of Influenza A virus PA (A/WSN/1933(H1N1)). The exact sequence is proprietary.
Purified by antigen-affinity chromatography.
For laboratory use only. Not for any clinical, therapeutic, or diagnostic use in humans or animals. Not for animal or human consumption.